NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

Citing Articles

Recurrence pattern and mapping of lymph node metastases from rectal neuroendocrine tumors.

Takaoka A, Tsukamoto S, Takamizawa Y, Moritani K, Imaizumi J, Kinugasa Y Int J Colorectal Dis. 2025; 40(1):52.

PMID: 39998663 PMC: 11861009. DOI: 10.1007/s00384-025-04820-1.

Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.

Uhlig J, Nie J, Gibson J, Cecchini M, Stein S, Lacy J Sci Rep. 2024; 14(1):30536.

PMID: 39690170 PMC: 11652651. DOI: 10.1038/s41598-024-81518-4.

Endoscopic Ultrasound-Guided Diagnosis of Gallbladder Mixed Neuroendocrine Non-Neuroendocrine Tumor With an Anomalous Pancreaticobiliary Junction.

Tsuchiyose E, Talanian M, Liao H, Holzwanger E ACG Case Rep J. 2024; 11(12):e01566.

PMID: 39641104 PMC: 11617348. DOI: 10.14309/crj.0000000000001566.

Update understanding on diagnosis and histopathological examination of atrophic gastritis: A review.

Ma X, Zhou N, Luo X, Guo S, Mai P World J Gastrointest Oncol. 2024; 16(10):4080-4091.

PMID: 39473965 PMC: 11514679. DOI: 10.4251/wjgo.v16.i10.4080.

Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives.

Badrane I, Urso L, Campenni A, Cittanti C, De Rimini M, Bartolomei M Endocrine. 2024; 87(1):67-72.

PMID: 39373830 DOI: 10.1007/s12020-024-04062-1.